Amundi’s Omnicell OMCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$988K Sell
29,613
-26,745
-47% -$1.12M ﹤0.01% 1289
2025
Q4
$2.55M Buy
56,358
+32,203
+133% +$1.18M ﹤0.01% 1123
2025
Q3
$737K Buy
24,155
+1,921
+9% +$59K ﹤0.01% 1223
2025
Q2
$663K Sell
22,234
-13,855
-38% -$414K ﹤0.01% 1303
2025
Q1
$1.23M Sell
36,089
-3,220
-8% -$128K ﹤0.01% 1278
2024
Q4
$1.69M Buy
39,309
+14,115
+56% +$634K ﹤0.01% 1244
2024
Q3
$1.08M Sell
25,194
-940
-4% -$35.4K ﹤0.01% 1276
2024
Q2
$699K Buy
26,134
+6,826
+35% +$198K ﹤0.01% 1287
2024
Q1
$526K Hold
19,308
﹤0.01% 1419
2023
Q4
$673K Sell
19,308
-9,245
-32% -$340K ﹤0.01% 1390
2023
Q3
$1.2M Sell
28,553
-15,275
-35% -$925K ﹤0.01% 1274
2023
Q2
$3.2M Buy
+43,828
New +$2.96M ﹤0.01% 1070
2023
Q1
Sell
-22,632
Closed -$1.24M 2105
2022
Q4
$1.24M Sell
22,632
-7,569
-25% -$455K ﹤0.01% 1270
2022
Q3
$2.62M Buy
+30,201
New +$3.17M ﹤0.01% 1105

Other funds holding OMCL

Amundi's OMCL Position: Q1 2026 in Review

Amundi reduced its Omnicell (OMCL) stake by 47% in Q1 2026, selling an estimated $1.12M and leaving 29,613 shares worth $988K. The position accounts for ﹤0.01% of the portfolio, ranked #1289.

Amundi first reported a position in OMCL in Q3 2022 and has held it in 14 quarters since. The position peaked at $3.2M in Q2 2023. 272 funds tracked by Wall St. Rank hold OMCL as of Q1 2026.

  • Amundi held 29,613 shares of Omnicell worth $988K as of Q1 2026.
  • Amundi sold 26,745 Omnicell shares in Q1 2026, an estimated $1.12M.
  • Omnicell made up ﹤0.01% of Amundi's portfolio in Q1 2026, its #1289 holding.
  • Amundi first reported a position in Omnicell in Q3 2022 and has held it in 14 quarters since.
  • Amundi's Omnicell position peaked at $3.2M in Q2 2023.
  • 272 funds tracked by Wall St. Rank held Omnicell as of Q1 2026.

Based on Amundi's 13F filing for Q1 2026, filed 18 May 2026.